Close Menu

This article has been updated to correct details regarding the Florida state license.

NEW YORK (GenomeWeb) – Colorectal cancer testing firm Clinical Genomics today said that it has received licensure from Florida authorities to offer its Colvera colorectal cancer test to residents of the state.

The license from the Florida Agency for Healthcare Administration allows the Bridgewater, New Jersey-based firm to offer the liquid biopsy test for identifying ctDNA for detecting residual disease and early detection of recurrence in post-treatment patients.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.